Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 28, 2013; 19(16): 2529-2536
Published online Apr 28, 2013. doi: 10.3748/wjg.v19.i16.2529
Table 2 Laboratory data assessment at baseline and after treatment
ParameterBase lineAfter 3 mo treatmentP value
Hemoglobin (g%)11.8 ± 2.112.2 ± 2.20.1
RBCs (× 106/μL)4.13 ± 0.94.3 ± 0.90.001
WBCs (× 103/μL)6.4 ± 2.15.6 ± 2.20.013
Platelets (× 103/μL)167.7 ± 91.2198.5 ± 1030.004
Hematocrit (%)35.5 ± 6.337.3 ± 6.30.056
ALT (IU/L)35.0 ± 15.741 ± 24.40.255
AST (IU/L)40.9 ± 30.446.8 ± 32.20.307
Total protein (g/dL)7.1 ± 0.77.5 ± 0.80.001
Albumin (g/dL)3.5 ± 0.93.69 ± 0.90.008
Direct bilirubin (mg/dL)0.5 ± 0.80.57 ± 1.50.745
Total bilirubin (mg/dL)1.46 ± 1.51.36 ± 1.30.428
Prothrombin time (s)14.1 ± 2.713.8 ± 2.20.562
INR1.18 ± 0.21.2 ± 0.20.974
BUN (mg/dL)13.5 ± 6.214.1 ± 50.540
Creatinin (mg/dL)0.99 ± 0.40.88 ± 0.20.102
Serum AFP (IU/mL)5.07 ± 1.84.67 ± 2.30.194
Sodium (mmole/L)135.5 ± 6.1133.5 ± 60.064
Potassium (mmole/L)4.1 ± 0.54 ± 0.50.350
TAC (mmol/L)1.35 ± 0.51.61 ± 0.60.001
Fasting blood sugar (mg/dL)104.03 ± 43.492.1 ± 31.30.001
Post prandial blood sugar (mg/dL)143.67 ± 72.6112.1 ± 42.90.001
PCR (copies)380808.7 ± 610937147028.2 ± 475225.60.001